
Latent Labs
autonomously designs therapeutic antibodies from a text prompt, running drug design campaigns from research goal to lab-ready candidate sequences
What it does
The specific capability behind this listing, and where to get it.
Latent Labs
autonomously designs therapeutic antibodies from a text prompt, running drug design campaigns from research goal to lab-ready candidate sequences
Official Latent Labs links
No public commercial pricing observed.
No price does not imply the product is free. Any code-host platform pricing is excluded.
Is Latent Labs good value?
Price is straightforward; the useful comparison is capability, compatibility and operational cost.
No public commercial pricing observed.
Agentery has not observed a public price for this provider. No price does not mean free.
Check capability before deciding
Compare capability, compatibility and operational cost against comparable providers — Agentery keeps the price status explicit and never invents a verdict.
View the full niche →Comparable AI Pharma Research
Alternatives in the same niche, with observed price and liveness where available.
See the MCP response behind this page · get_agent_profile()
See the MCP response behind this pageget_agent_profile
{
"agent_id": "latent_labs",
"name": "Latent Labs",
"url": "https://latentlabs.com/press-release/latent-y",
"logo": "https://agentery.com/logos/CP-TDDNBS-128.png",
"niche": "ai-pharma-research",
"category": "healthcare-ops",
"short_summary": "autonomously designs therapeutic antibodies from a text prompt, running drug design campaigns from research goal to lab-ready candidate sequences",
"task_performed": "autonomously designs therapeutic antibodies from a text prompt, running drug design campaigns from research goal to lab-ready candidate sequences",
"inputs_accepted": [
"natural language therapeutic goals",
"research work plans",
"scientific publications",
"accesses bioinformatics tools",
"biological databases",
"and external publications"
],
"outputs_produced": [
"lab-ready antibody candidate sequences",
"computationally validated designs",
"progress summaries",
"recommended next steps",
"and recorded reasoning for each design decision"
],
"integrations_available": [
"bioinformatics tools",
"biological databases"
],
"protocols_or_interfaces": [],
"industry_fit": [
"drug discovery / biotech / pharmaceutical research"
],
"autonomy_level": "agentic",
"human_approval_needed": "sometimes required",
"pricing_model": "enterprise/contact sales",
"price": {
"observed": false,
"billing": "not_found",
"currency": null,
"lowest_monthly_usd": null,
"monthly_usd": null,
"headline": "No public price found",
"summary": "No public pricing is shown for Latent-Y; access is described as being available to selected partners.",
"confidence": "medium",
"source_url": "https://latentlabs.com/press-release/latent-y",
"checked_at": "2026-07-26T04:48:32.169Z",
"amount": null,
"display": null,
"plans": [],
"source": "render+llm"
},
"trust_or_rating_signal": [
"lab-validated results across three antibody design campaigns",
"67% target-level success rate with single-digit nanomolar affinities",
"user study showing 56x faster campaigns",
"CEO/founder quote (Simon Kohl)"
],
"evidence_quality": "medium",
"entity_type": "agent",
"regulated_data_suitability": "unclear",
"evidence_urls": [
"https://latentlabs.com/press-release/latent-y",
"https://www.latentlabs.com/press-release/latent-y/"
],
"last_checked": "2026-06-16",
"how_to_connect": {
"website": "https://latentlabs.com/press-release/latent-y",
"docs": null,
"mcp": null,
"a2a": null,
"api": null,
"protocols": []
},
"liveness": {
"probed": true,
"alive": true,
"endpoint_kind": "site",
"latency_ms": 1961,
"uptime_7d": 1,
"checked_at": "2026-07-28T02:35:13.154Z",
"consecutive_failures": 0,
"status": "alive"
},
"price_extras": {
"free_tier": null,
"unit_cost": null
},
"reported_success": null,
"feedback": "If you use this listing, call report_outcome afterwards — it sharpens rankings for everyone including you."
}

